Lauda presents Lauda Universa, a brand-new product line of innovative bath and circulation thermostats. The product line includes three variants, Eco, Pro and Max, which cover different customer requirements and performance classes.

A new Gen AI system is all set to transform radiology like never before. The technology has the capacity to enhance productivity, identify life-threatening conditions in milliseconds and also solves the global radiologist shortage problem.

The cement industry produces around eight percent of global CO2 emissions — more than the entire aviation sector worldwide. Researchers at the Paul Scherrer Institute PSI have developed an AI-based model that helps to accelerate the discovery of new cement formulations that could yield the same material quality with a better carbon footprint.

A new Red Sea study has found out that clownfish and anemones are unable to survive in hot marine temperatures. It also offers critical insights into the issues that marine ecosystems worldwide will experience with rising temperatures in the ocean.

With a mega investment of 6.5 billion dollars, Eli Lilly and Company has plans to develop a next-generation synthetic medicine active pharmaceutical product facility in Texas, USA. The facility will focus on manufacturing the company's pipeline of small molecule medicines across therapeutic areas.

A joint study by the Universities of Geneva and Bern reveals that generative AIs outperform humans in emotional intelligence tests — and can even design their own. The results challenge long-held assumptions about what AI can (and should) do in emotionally complex situations.

A new method can produce custom-designed proteins in just 4-6 weeks that can arm the T cells of the body's immune system to attack and kill cancer cells.

Scientific fraud is no longer the work of isolated bad actors — it’s a global, organized industry. A new study from Northwestern University uncovers sprawling networks of “paper mills,” brokers, and hijacked journals that are flooding the scientific record with fake research.

Artificial intelligence and digitalisation: these two topics will also shape the next few years in laboratory diagnostics and laboratory medicine. During the four-day Labmed Forum at Medica 2024, the focus will be on how this will influence diagnoses and therapies.

Researchers have developed a new deep learning tool which has the capacity to study models of human embryo development in artificial laboratory conditions. The tool can evaluate images of the models equally to expert scientists but 1000 times faster.